TCL Archive US Oncology Begins Phase III Trial Of Bcl-2 Antisense With Chemo For Melanoma. July 28, 2000
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004